Seeking Alpha

Allergan (AGN -3.5%) dips after its Q3 swung to a profit on strong specialty pharmaceutical...

Allergan (AGN -3.5%) dips after its Q3 swung to a profit on strong specialty pharmaceutical sales, but the company's issues cautious Q4 guidance below Street estimates. It now forecasts current-quarter earnings of between $0.97 - $0.99 per share on sales of $1.33B to $1.41B, below analysts expectations for an EPS of $1.01 on revenue of $1.41B.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs